{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:39:39Z","timestamp":1790192379000,"version":"4.1.0"},"reference-count":32,"publisher":"American Diabetes Association","issue":"5","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,5,1]]},"abstract":"<jats:p>OBJECTIVE\u2014The purpose of this study was to compare the predictive value for coronary heart disease (CHD) of the International Diabetes Federation (IDF) definition (with Asian criteria for central obesity) of the metabolic syndrome with existing criteria of the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) in Chinese subjects with type 2 diabetes.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014Subjects with type 2 diabetes and without macrovascular diseases or end-stage renal disease were categorized by the criteria of the IDF and the NCEP ATP III. CHD was defined as myocardial infarction, ischemic heart disease, coronary revascularization, heart failure, and death related to CHD.<\/jats:p>\n               <jats:p>RESULTS\u2014Of 4,350 patients (aged 54.4 \u00b1 13.4 years; median follow-up period 7.1 [interquartile range 5.2\u20138.5] years), 65.9% had metabolic syndrome according to either IDF or NCEP ATP III criteria. The NCEP ATP III definition identified metabolic syndrome in 786 subjects (18.1%) who did not fulfill the criteria of the IDF. HDL cholesterol and systolic blood pressure were predictors of CHD after adjustment for other confounding factors. Compared with subjects without metabolic syndrome, the IDF criteria failed to predict CHD (hazard ratio 1.13 [95% CI 0.86\u20131.48], P = 0.374). In contrast, the NCEP ATP III definition (2.51 [1.80\u20133.50], P &amp;lt; 0.001) predicted an increased risk of CHD with the NCEP-only group having the highest risk (2.49 [1.66\u20133.73], P &amp;lt; 0.001).<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014With established type 2 diabetes, the IDF definition of the metabolic syndrome failed to identify a subgroup of patients who had the highest risk for CHD. Practitioners must recognize the appropriate setting for its application.<\/jats:p>","DOI":"10.2337\/dc06-1484","type":"journal-article","created":{"date-parts":[[2007,4,27]],"date-time":"2007-04-27T17:29:23Z","timestamp":1177694963000},"page":"1206-1211","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":101,"title":["The Usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III Definitions of the Metabolic Syndrome in Predicting Coronary Heart Disease in Subjects With Type 2 Diabetes"],"prefix":"10.2337","volume":"30","author":[{"given":"Peter C.","family":"Tong","sequence":"first","affiliation":[{"name":"Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, NT, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice P.","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, NT, Hong Kong"},{"name":"Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, NT, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-Yee","family":"So","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, NT, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, NT, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Shun","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, NT, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, NT, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, NT, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chung","family":"Chow","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, NT, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, NT, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana C.N.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, NT, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive S.","family":"Cockram","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, NT, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031219411624200_R1","doi-asserted-by":"crossref","unstructured":"Klein BE, Klein R, Lee KE: Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care\u200825: 1790\u20131794, 2002","DOI":"10.2337\/diacare.25.10.1790"},{"key":"2022031219411624200_R2","doi-asserted-by":"crossref","unstructured":"Malik S, Wong ND, Franklin S, Pio J, Fairchild C, Chen R: Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care\u200828:690\u2013693, 2005","DOI":"10.2337\/diacare.28.3.690"},{"key":"2022031219411624200_R3","doi-asserted-by":"crossref","unstructured":"McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G: The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care\u200828:385\u2013390, 2005","DOI":"10.2337\/diacare.28.2.385"},{"key":"2022031219411624200_R4","doi-asserted-by":"crossref","unstructured":"Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care\u200824:683\u2013689, 2001","DOI":"10.2337\/diacare.24.4.683"},{"key":"2022031219411624200_R5","doi-asserted-by":"crossref","unstructured":"Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA\u2008288:2709\u20132716, 2002","DOI":"10.1001\/jama.288.21.2709"},{"key":"2022031219411624200_R6","doi-asserted-by":"crossref","unstructured":"Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med\u200815:539\u2013553, 1998","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"2022031219411624200_R7","doi-asserted-by":"crossref","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation\u2008106:3143\u20133421, 2002","DOI":"10.1161\/circ.106.25.3143"},{"key":"2022031219411624200_R8","doi-asserted-by":"crossref","unstructured":"Balkau B, Charles MA: Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR). Diabet Med\u200816:442\u2013443, 1999","DOI":"10.1046\/j.1464-5491.1999.00059.x"},{"key":"2022031219411624200_R9","doi-asserted-by":"crossref","unstructured":"Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet\u2008365:1415\u20131428, 2005","DOI":"10.1016\/S0140-6736(05)66378-7"},{"key":"2022031219411624200_R10","doi-asserted-by":"crossref","unstructured":"WHO Expert Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet\u2008363:157\u2013163, 2004","DOI":"10.1016\/S0140-6736(03)15268-3"},{"key":"2022031219411624200_R11","doi-asserted-by":"crossref","unstructured":"Tan CE, Ma S, Wai D, Chew SK, Tai ES: Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care\u200827:1182\u20131186, 2004","DOI":"10.2337\/diacare.27.5.1182"},{"key":"2022031219411624200_R12","doi-asserted-by":"crossref","unstructured":"Alberti KG, Zimmet P, Shaw J: The metabolic syndrome\u2014a new worldwide definition. Lancet\u2008366:1059\u20131062, 2005","DOI":"10.1016\/S0140-6736(05)67402-8"},{"key":"2022031219411624200_R13","doi-asserted-by":"crossref","unstructured":"Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care\u200828:2289\u20132304, 2005","DOI":"10.2337\/diacare.28.9.2289"},{"key":"2022031219411624200_R14","doi-asserted-by":"crossref","unstructured":"Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, Katayama S, Saito Y, Ito H, Ohashi Y, Akanuma Y, Yamada N: Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care\u200828:1463\u20131471, 2005","DOI":"10.2337\/diacare.28.6.1463"},{"key":"2022031219411624200_R15","doi-asserted-by":"crossref","unstructured":"Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M: Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative: the DIABCARE Monitoring Group of the St Vincent Declaration Steering Committee. Diabet Med\u200810:371\u2013377, 1993","DOI":"10.1111\/j.1464-5491.1993.tb00083.x"},{"key":"2022031219411624200_R16","doi-asserted-by":"crossref","unstructured":"Tong PC, Lee KF, So WY, Ng MH, Chan WB, Lo MK, Chan NN, Chan JC: White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes. Diabetes Care\u200827:216\u2013222, 2004","DOI":"10.2337\/diacare.27.1.216"},{"key":"2022031219411624200_R17","doi-asserted-by":"crossref","unstructured":"Mogensen CE, Vestbo E, Poulsen PL, Christiansen C, Damsgaard EM, Eiskjaer H, Froland A, Hansen KW, Nielsen S, Pedersen MM: Microalbuminuria and potential confounders: a review and some observations on variability of urinary albumin excretion. Diabetes Care\u200818:572\u2013581, 1995","DOI":"10.2337\/diacare.18.4.572"},{"key":"2022031219411624200_R18","doi-asserted-by":"crossref","unstructured":"Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol\u200817:2937\u20132944, 2006","DOI":"10.1681\/ASN.2006040368"},{"key":"2022031219411624200_R19","doi-asserted-by":"crossref","unstructured":"Kannel WB, Wilson PW, Zhang TJ: The epidemiology of impaired glucose tolerance and hypertension. Am Heart J\u2008121:1268\u20131273, 1991","DOI":"10.1016\/0002-8703(91)90432-H"},{"key":"2022031219411624200_R20","doi-asserted-by":"crossref","unstructured":"Barrett-Connor E, Grundy SM, Holdbrook MJ: Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol\u2008115:657\u2013663, 1982","DOI":"10.1093\/oxfordjournals.aje.a113348"},{"key":"2022031219411624200_R21","doi-asserted-by":"crossref","unstructured":"Chan WB, Tong PC, Chow CC, So WY, Ng MC, Ma RC, Osaki R, Cockram CS, Chan JC: The associations of body mass index, C-peptide and metabolic status in Chinese type 2 diabetic patients. Diabet Med\u200821:349\u2013353, 2004","DOI":"10.1111\/j.1464-5491.2004.01158.x"},{"key":"2022031219411624200_R22","doi-asserted-by":"crossref","unstructured":"Sone H, Tanaka S, Ishibashi S, Yamasaki Y, Oikawa S, Ito H, Saito Y, Ohashi Y, Akanuma Y, Yamada N: The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions: additional analysis from the Japan Diabetes Complications Study. Diabetes Care\u200829:145\u2013147, 2006","DOI":"10.2337\/diacare.29.01.06.dc05-1341"},{"key":"2022031219411624200_R23","doi-asserted-by":"crossref","unstructured":"Wu AY, Kong NC, de Leon FA, Pan CY, Tai TY, Yeung VT, Yoo SJ, Rouillon A, Weir MR: An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) study. Diabetologia\u200848:17\u201326, 2005","DOI":"10.1007\/s00125-004-1599-9"},{"key":"2022031219411624200_R24","doi-asserted-by":"crossref","unstructured":"Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia\u200832:219\u2013226, 1989","DOI":"10.1007\/BF00285287"},{"key":"2022031219411624200_R25","doi-asserted-by":"crossref","unstructured":"Dinneen SF, Gerstein HC: The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med\u2008157:1413\u20131418, 1997","DOI":"10.1001\/archinte.157.13.1413"},{"key":"2022031219411624200_R26","unstructured":"Feldt-Rasmussen B: Microalbuminuria, endothelial dysfunction and cardiovascular risk. Diabetes Metab\u200826(Suppl. 4):64\u201366, 2000"},{"key":"2022031219411624200_R27","doi-asserted-by":"crossref","unstructured":"Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T: Features of endothelial dysfunction in early diabetic nephropathy. Lancet\u20081:461\u2013463, 1989","DOI":"10.1016\/S0140-6736(89)91365-2"},{"key":"2022031219411624200_R28","doi-asserted-by":"crossref","unstructured":"Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet\u2008340:319\u2013323, 1992","DOI":"10.1016\/0140-6736(92)91401-S"},{"key":"2022031219411624200_R29","doi-asserted-by":"crossref","unstructured":"Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D: C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int\u200863:654\u2013661, 2003","DOI":"10.1046\/j.1523-1755.2003.00762.x"},{"key":"2022031219411624200_R30","doi-asserted-by":"crossref","unstructured":"Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN: The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care\u200829:404\u2013409, 2006","DOI":"10.2337\/diacare.29.02.06.dc05-1636"},{"key":"2022031219411624200_R31","doi-asserted-by":"crossref","unstructured":"Qiao Q: Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia\u200849:2837\u20132946, 2006","DOI":"10.1007\/s00125-006-0438-6"},{"key":"2022031219411624200_R32","doi-asserted-by":"crossref","unstructured":"Yoon YS, Lee ES, Park C, Lee S, Oh SW: The new definition of metabolic syndrome by the International Diabetes Federation is less likely to identify metabolically abnormal but nonobese individuals than the definition by the revised national cholesterol education program: The Korea NHANES study. Int J Obes (Lond)\u200831:528\u2013534, 2006","DOI":"10.1038\/sj.ijo.0803442"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/30\/5\/1206\/596967\/zdc00507001206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/30\/5\/1206\/596967\/zdc00507001206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T21:22:23Z","timestamp":1647120143000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/30\/5\/1206\/29964\/The-Usefulness-of-the-International-Diabetes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,1]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc06-1484","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,1]]}}}